These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9625815)

  • 1. Regulation of insulin-like growth factor (IGF) II and IGF binding protein 3 autocrine loop in human PC-3 prostate cancer cells by vitamin D metabolite 1,25(OH)2D3 and its analog EB1089.
    Huynh H; Pollak M; Zhang JC
    Int J Oncol; 1998 Jul; 13(1):137-43. PubMed ID: 9625815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of insulin- and insulin-like growth factor-I-stimulated growth of human breast cancer cells by 1,25-dihydroxyvitamin D3 and the vitamin D3 analogue EB1089.
    Vink-van Wijngaarden T; Pols HA; Buurman CJ; Birkenhäger JC; van Leeuwen JP
    Eur J Cancer; 1996 May; 32A(5):842-8. PubMed ID: 9081364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of proliferation of prostate epithelial cells by 1,25-dihydroxyvitamin D3 is accompanied by an increase in insulin-like growth factor binding protein-3.
    Sprenger CC; Peterson A; Lance R; Ware JL; Drivdahl RH; Plymate SR
    J Endocrinol; 2001 Sep; 170(3):609-18. PubMed ID: 11524241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D analogue EB1089-induced prostate regression is associated with increased gene expression of insulin-like growth factor binding proteins.
    Nickerson T; Huynh H
    J Endocrinol; 1999 Feb; 160(2):223-9. PubMed ID: 9924191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic low-calcaemic vitamin D(3) analogues inhibit secretion of insulin-like growth factor II and stimulate production of insulin-like growth factor-binding protein-6 in conjunction with growth suppression of HT-29 colon cancer cells.
    Oh YS; Kim EJ; Schaffer BS; Kang YH; Binderup L; MacDonald RG; Park JH
    Mol Cell Endocrinol; 2001 Oct; 183(1-2):141-9. PubMed ID: 11604234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiproliferative action of vitamin D-related compounds and insulin-like growth factor-binding protein 5 accumulation.
    Rozen F; Yang XF; Huynh H; Pollak M
    J Natl Cancer Inst; 1997 May; 89(9):652-6. PubMed ID: 9150190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of insulin-like growth factor I receptor signaling by the vitamin D analogue EB1089 in MCF-7 breast cancer cells: A role for insulin-like growth factor binding proteins.
    Rozen F; Pollak M
    Int J Oncol; 1999 Sep; 15(3):589-94. PubMed ID: 10427145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of insulin-like growth factor binding proteins in 1alpha,25-dihydroxyvitamin D(3)-induced growth inhibition of human prostate cancer cells.
    Stewart LV; Weigel NL
    Prostate; 2005 Jun; 64(1):9-19. PubMed ID: 15651061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autocrine regulation of cell proliferation by the insulin-like growth factor (IGF) and IGF binding protein-3 protease system in a human prostate carcinoma cell line (PC-3).
    Angelloz-Nicoud P; Binoux M
    Endocrinology; 1995 Dec; 136(12):5485-92. PubMed ID: 7588299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D derivatives inhibit the mitogenic effects of IGF-I on MCF-7 human breast cancer cells.
    Xie SP; James SY; Colston KW
    J Endocrinol; 1997 Sep; 154(3):495-504. PubMed ID: 9379127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DHT and testosterone, but not DHEA or E2, differentially modulate IGF-I, IGFBP-2, and IGFBP-3 in human prostatic stromal cells.
    Le H; Arnold JT; McFann KK; Blackman MR
    Am J Physiol Endocrinol Metab; 2006 May; 290(5):E952-60. PubMed ID: 16368782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in localized, metastasized prostate cancer and benign prostatic hyperplasia.
    Aksoy Y; Aksoy H; Bakan E; Atmaca AF; Akçay F
    Urol Int; 2004; 72(1):62-5. PubMed ID: 14730168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1,25-Dihydroxyvitamin D3 differentially regulates the production of insulin-like growth factor I (IGF-I) and IGF-binding protein-4 in mouse osteoblasts.
    Scharla SH; Strong DD; Mohan S; Baylink DJ; Linkhart TA
    Endocrinology; 1991 Dec; 129(6):3139-46. PubMed ID: 1720089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor (IGF)-binding protein-3 mutants that do not bind IGF-I or IGF-II stimulate apoptosis in human prostate cancer cells.
    Hong J; Zhang G; Dong F; Rechler MM
    J Biol Chem; 2002 Mar; 277(12):10489-97. PubMed ID: 11784719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a functional vitamin D response element in the human insulin-like growth factor binding protein-3 promoter.
    Peng L; Malloy PJ; Feldman D
    Mol Endocrinol; 2004 May; 18(5):1109-19. PubMed ID: 14963110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretion of insulin-like growth factors and their binding proteins by human normal and hyperplastic prostatic cells in primary culture.
    Boudon C; Rodier G; Lechevallier E; Mottet N; Barenton B; Sultan C
    J Clin Endocrinol Metab; 1996 Feb; 81(2):612-7. PubMed ID: 8636277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of gene Expression by 1alpha,25-dihydroxyvitamin D3 and Its analog EB1089 under growth-inhibitory conditions in squamous carcinoma Cells.
    Akutsu N; Lin R; Bastien Y; Bestawros A; Enepekides DJ; Black MJ; White JH
    Mol Endocrinol; 2001 Jul; 15(7):1127-39. PubMed ID: 11435613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of proliferation of PC-3 human prostate cancer by antagonists of growth hormone-releasing hormone: lack of correlation with the levels of serum IGF-I and expression of tumoral IGF-II and vascular endothelial growth factor.
    Plonowski A; Schally AV; Letsch M; Krupa M; Hebert F; Busto R; Groot K; Varga JL
    Prostate; 2002 Aug; 52(3):173-82. PubMed ID: 12111694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiproliferative action of tumor necrosis factor-alpha on MCF-7 breastcancer cells is associated with increased insulin-like growth factor binding protein-3 accumulation.
    Rozen F; Zhang J; Pollak M
    Int J Oncol; 1998 Oct; 13(4):865-9. PubMed ID: 9735418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1alpha,25-dihydroxyvitamin D3 induced growth inhibition of PC-3 prostate cancer cells requires an active transforming growth factor beta signaling pathway.
    Murthy S; Weigel NL
    Prostate; 2004 May; 59(3):282-91. PubMed ID: 15042604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.